
Alert: New Earnings Report (8/7/24)-Catalyst Pharmaceutical Inc (NASDAQ: CPRX).
For its second fiscal quarter (ending June 30), Catalyst Pharmaceutical Inc (NASDAQ: CPRX) has reported a -3% decline in E.P.S. from $0.36 a year ago to $0.35 in the current quarter. This performance was $-0.08 […]